HIV-1 Reverse Transcriptase: A Therapeutical Target in the Spotlight

E-ISSN： 1875-533x|13|3|313-324

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.13, Iss.3, 2006-02, pp. : 313-324

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of HIV-1 Reverse Transcriptase and Integrase: Classical and Emerging Therapeutical Approaches

Current Pharmaceutical Design, Vol. 8, Iss. 8, 2002-04 ,pp. : 595-614

Bentham Science Publishers

Access to resources Recommend Favorite

HIV-1 reverse transcriptase inhibitors

By Krawczyk Sören Hilgeroth Andreas

PHARMAKON, Vol. 2, Iss. 4, 2014-07 ,pp. : 270-276

Govi-Verlag

Access to resources Recommend Favorite

Non-nucleoside inhibitors of HIV-1 reverse transcriptase

By Proudfoot J.R.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 8, 1998-08 ,pp. : 971-982

Informa Healthcare

Access to resources Recommend Favorite

HIV-1 non-nucleoside reverse transcriptase inhibitors

By Högberg M. Morrison I.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 8, 2000-08 ,pp. : 1189-1199

Informa Healthcare

Access to resources Recommend Favorite

Human immunodeficiency virus 1 (HIV-1) reverse transcriptase (RT)

By Argyris E. Paterson Y.

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 2, 1998-12 ,pp. : 239-243

Informa Healthcare

Access to resources Recommend Favorite